Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00055068 · ClinicalTrials.gov registry record · Phase 3

Family Based Treatment of Early Childhood Obsessive Compulsive Disorder

A Phase 3 study of Obsessive - Compulsive Disorder, sponsored by Rhode Island Hospital.

Completed
Registry status
Phase 3
Development phase
38
Enrollment target
1
Study location

NCT00055068 is a Phase 3 study of Obsessive - Compulsive Disorder that has completed, run by Rhode Island Hospital. The registered enrollment target is 38 participants, below the 2,064-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00055068, a Phase 3 study of Obsessive - Compulsive Disorder, has completed, sponsored by Rhode Island Hospital.

COMPLETED
Registry status
Phase 3
Development phase
38 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate a treatment program for young children with Obsessive Compulsive Disorder (OCD) and their families.

Interventions

  • BEHAVIORAL Cognitive Behavioral Therapy (CBT)
  • BEHAVIORAL Relaxation Training

Study Locations (1)

Rhode Island

  • Rhode Island Hospital/Brown University - Providence

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2002-03
Est. Completion 2006-02
Phase Phase 3

Sponsor

Rhode Island Hospital

130 total trials

What the Registry Record Tells You About NCT00055068

The ClinicalTrials.gov registry entry for NCT00055068 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,064-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (98% lower). The listed sponsor is Rhode Island Hospital, which has 130 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obsessive - Compulsive Disorder appearing as the primary indexed condition, and to 2 interventions - of which Cognitive Behavioral Therapy (CBT) is the first listed.

NCT00055068 reports 1 study location spanning 1 distinct geographic area - top geographies include Rhode Island.

Frequently Asked Questions

What is clinical trial NCT00055068 about?

NCT00055068 is a clinical study titled "Family Based Treatment of Early Childhood Obsessive Compulsive Disorder". This study will evaluate a treatment program for young children with Obsessive Compulsive Disorder (OCD) and their families.

What is the current status of trial NCT00055068?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 38 participants. The study started on 2002-03. Estimated completion is 2006-02.

What conditions does trial NCT00055068 study?

This clinical trial studies the following conditions: Obsessive - Compulsive Disorder.

What interventions are being tested in trial NCT00055068?

The interventions under investigation include: Cognitive Behavioral Therapy (CBT) (BEHAVIORAL), Relaxation Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT00055068?

This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00055068 being conducted?

This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obsessive - Compulsive Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.